Related Experiment Videos
Spermine and spermidine are non-specific inhibitors of in vitro hematopoiesis
Abstract:
The polyamine spermine has been reported to be the inhibitor of in vitro erythropoiesis present in uremic serum. We have employed a panel of hematopoietic colony-forming assays to evaluate the specificity of the inhibitory activity. Spermine and its precursor spermidine when added to culture inhibited mouse and human erythroid (CFU-E and BFU-E), granulocyte-macrophage, and megakaryocyte colony growth in a non-specific, dose-dependent fashion. Erythroid and non-erythroid colony growth were equally sensitive to spermine- and spermidine-induced inhibition. Increasing concentrations in culture of erythropoietin and mitogen-stimulated leukocyte-conditioned medium, a source of colony-stimulating activity, failed to overcome the in vitro inhibition. Although anemia is characteristic of chronic renal failure (CRF), leukopenia and thrombocytopenia are not. Therefore, we conclude that the non-specific inhibitory activity of spermine and spermidine, as defined by in vitro colony assays, is either of no pathophysiologic significance in the anemia of CRF, or else there are unrecognized repair mechanisms in vivo which maintain granulopoiesis and thrombopoiesis at normal levels.
Insights
Spermine and spermidine non-specifically inhibit blood cell formation in vitro. This suggests these polyamines may not cause anemia in chronic renal failure (CRF) due to unknown in vivo repair mechanisms.
Area of Science:
- Hematology
- Biochemistry
- Renal Medicine
Background:
- Uremic serum contains inhibitors of erythropoiesis, with spermine identified as a potential culprit.
- The specific role of spermine in the anemia of chronic renal failure (CRF) requires further investigation.
Purpose of the Study:
- To evaluate the specificity of spermine's inhibitory activity on hematopoietic progenitor cells.
- To determine the potential pathophysiological significance of spermine and spermidine in CRF-related cytopenias.
Main Methods:
- Utilized a panel of hematopoietic colony-forming assays for mouse and human cell cultures.
- Assessed the dose-dependent inhibitory effects of spermine and spermidine on erythroid (CFU-E, BFU-E), granulocyte-macrophage, and megakaryocyte colony growth.
- Investigated the ability of erythropoietin and colony-stimulating factors to overcome polyamine-induced inhibition.
Main Results:
- Spermine and spermidine demonstrated non-specific, dose-dependent inhibition of all tested hematopoietic lineages (erythroid, granulocyte-macrophage, megakaryocyte) in vitro.
- Both erythroid and non-erythroid colony growth showed equal sensitivity to spermine and spermidine.
- Exogenous erythropoietin and colony-stimulating factors did not reverse the inhibitory effects of spermine and spermidine in culture.
Conclusions:
- The non-specific in vitro inhibitory activity of spermine and spermidine on hematopoiesis is likely not the primary cause of anemia in CRF.
- Unidentified in vivo compensatory mechanisms may preserve granulopoiesis and thrombopoiesis despite the presence of these polyamines in CRF.
- Further research is needed to elucidate the precise mechanisms underlying the anemia of CRF and the role of polyamines.